東美實業有限公司

 COVID-19 Antigen Rapid Test Cassette (Swab) 
Designed for qualitative detection of SARS-CoV-2 antigen in Swabs

 SARS-CoV-2 Nucleocapsid Protein Detection 
Nucleocapsid [N] protein is the most abundant protein with highly conserved in SARS Cov 2. N protein is used as the core raw material of rapid diagnostic reagent for immunalogy in the market.

 COVID-19 Antigen Rapid Test Cassette 
We has developed the COVID-19 Antigen Rapid Test Cassette. The colloidal gald immunoassay (CGIA) to detect nucleacapsid protein of SARS-CoV-2 is based on the principle of the double antibody -sandwich technique.

The combination of COVID-19 Antigen Rapid Test and COVID-19 IgG/IgM Rapid Test can improve the accuracy of SARS-CoV-2 (COVID-19) detection. We also can provide the COVID-19 IgG/IgM Rapid Test Cassette. Please contact us for more information.

COVID-19 Antigen Rapid Test Cassette (Swab)

COVID 19 Antigen Rapid Test Cassette Swab

 COVID-19 IgG/IgM Rapid Test &amp; SARS-CoV-2 Proteins 

Serological immunoassay is an important auxiliary method for the diagnosis of COVID-19. The combination with molecular diagnostic is helpful to improve the accuracy of COVID-19 detection.&nbsp;
-&nbsp;Result available in 10-15 minutes.
- Whole blood, serum and Easy storage, 4-30&deg;C.

The colloidal gold immunoassay (CGIA) to detect COVID-19 utilizes the specific reaction between anti gen and antibody to detect the anti-SARS-CoV-2 antibody in patients&#39; sample. The advantages of CGIA is fast and convenient, stable sample collection, high throughput, and the result can be interpreted by naked eye.

 Product Features: 
COVID-19 IgM: 167 clinical specimens from individuals suspected of COVID-19 infection were detected by COVID-19 IgG/IgM rapid test cassette of CLONGENE&reg;, The result was compared with that of RT-PCR.

 Reproducibility: 
0 clinical serum specimens include 20 negative, 20 borderline positive and 20 posi- tive were tested in three physician office laboratories (POL), and each specimen was tested for three days at each POL. The intra-assay agreements and the in- ter-site agreement was both 100%.

 Specificity: 
- No cross reactivity was observed with specimens from patients infected with HIV, HAV, HBSAG, HCV, TP, HTLV, CMV, FLUA, FLUB, RSV, MP, CP, HPIVs.
-&nbsp;Common serum components, such as albumin, bilirubin, hemoglobin, et. al., do not Interfere with the COVID-19 IgG/IgM rapid test cassette of CLONGENEⓇ
- No cross reactivity or interference was observed with common biological analytes.

COVID-19 Rapid Test

COVID 19 Rapid Test for quick and accurate detection

流行工坊有限公司

 	 Customized name&nbsp; 	 IP black 	 Total weight: 6 grams 	 Dimensions: 30 x 21.3 mm  

Covid-19 HERO Brooch / Pin

 	 316L stainless steel 	 IP black 	 Total weight: 26 grams  

Covid-19 HERO Keychain

Covid 19 HERO Keychain made of stainless steel

ELIN Medical Products Co., Ltd.

Beijing Tigsun COVID-19 Antigen Rapid Test employs Immunochromatography technology to detect the SARS-CoV-2 antigen in human respiratory secretion specimens with swab sample by Lateral Flow Method. It offers lab-quality results at the point of care testing with reliable performance in 15 minutes.                                                                 Advantages: ⭐️ CE Certified, enrolled in WHO FIND list. ⭐️High accuracy (&gt;97%). ⭐️No-invasive with Saliva + Swab. ⭐️Result in 15 minutes, without any instrument. ⭐️All components included, with swab. ⭐️Room temperature store and transport. ⭐️Application : Applicable to customs inspection, public screening in airports or schools, and suspected persons with close contact or under quarantine control. 

COVID-19 Antigen Rapid Test 

Meiko Tins Industries Company

 	 55cm*40cm*42cm 	 10kg 	 SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit (Colloidal Gold) 	 Include: Desiccant, Disposable test card, cotton swabs, Peripheral blood collector, disposable plastic dropper, sample diluent  

sARsˉCoVˉ2(CoVIDˉ 19)IglΙ /IgG Antibody Fast DetectioⅡ Kit(ColIoidaI Gold)

sARs CoV 2 COVID 19 IgG Antibody Fast Detection Kit

 	 Colloidal Gold method for qualitative detection antibodies to Coronavirus infectious disease COVID-19 caused by SARS-CoV-2 virus in whole blood (peripheral blood)/serum/plasma. 	 Country of Origin: Jiangsu province,&nbsp;P.R. China&nbsp; 	 Packing: Individual pack in one aluminium foil bag of the test cassette and full accessories of Dryer, Safety Lancer, Buffer and Dropper&nbsp; 	 Target the individuals and to be tested by themselves at home, communities, offices and working places and act as a supplement to screen the majority of people rapidly, a cheaper and effective way to ease the pressure in government sectors&nbsp; 	 CE and FDA certification  

SARS-CoV-2 Rapid Test Cassette to COVID-19

SARS CoV 2 Rapid Test Cassette to COVID 19

Enjoy Group (HK) Co Ltd

 	 COVID-19 Diagnosis and Treatment Plan (Trial Version 7) 	 IgM/IgG antibody test is included in the diagnostic criteria! 	 On March 3, 2020, the National Health Commission of the People&#39;s Republic of China issued 	 &quot;COVID-19 Diagnosis and Treatment Plan (Trial Version 7)n&nbsp;and interpreted it. The latest diagnostic  Criteria are: 	 Explain the &quot;clustered disease cases&quot; in epidemiology; that is, &quot;2 or more cases of fever and/or respiratory symptoms in a small area such as family; office, school class, etc. within 2 weeks.&quot; 	 The &quot;decreased lymphocyte count&quot; in clinical manifestations is replaced with &quot;normal or decreased lymphocyte count.&quot; 	 On the basis of nucleic acid test and sequencing, &quot;serological test&quot; is newly added for disease case determination, that is, wSARS-CoV-2 specific IgM antibodies and IgG antibodies are positive&quot; or&quot;SARS-CoV-2 specific IgG antibodies are changed from negative to positive, or increased by 4 times or higher in recovery phase compared with acute phase&quot; is applicable to disease determination. 	 In addition, serological test has been added to clinical manifestations: SARS-CoV-2 specific IgM antibodies are mostly positive after 3~5 days of onset; IgG antibody titer is increased by 4 times or higher during recovery phase compared with acute phase. 	 Source: Central People&#39;s Government of the People&#39;s Republic of China 	 http://www.gov.cn 	 IgM and IgG are the first antibodies appearing in the human immune system during infection. When detecting acute SARS-CoV-2 infection, IgM and IgG antibodies have the advantages of high sensitivity, early diagnosis, and the ability to judge whether a suspect is infected. 	 IgM and IgG antibodies can only be produced after several days of viral infection, and the specific time may vary between individuals. 	 Port:&nbsp;Multiple locations can be specified  

我的採購

確定要取消關注此供應商？

確定要取消關注此供應商？